Latest Neurology Stories
Lee Rannals for redOrbit.com – Your Universe Online Researchers have created a gel that can be painted onto the walls of blood vessels, which could eventually help save lives. The gel can help to prevent the inflammation that typically occurs when a stent is inserted to widen a narrowed artery or vein. This inflammation often counteracts the opening of the vessel that the stent was intended to achieve. The team wrote about the gel in the current issue of the online journal...
Neurosurgeons at All Children's Hospital/Johns Hopkins Medicine (St. Petersburg, FL) and the University of South Florida Morsani College of Medicine (Tampa, FL) recently achieved excellent physical and aesthetic results in an infant born with extreme macrocephaly due to hydrocephalus. This was accomplished with routine implantation of a ventriculoperitoneal shunt followed by a new operation to stabilize and reduce the size of the baby's head. Both surgeries were performed during the infant's...
BOCA RATON, Fla., Dec. 10, 2012 /PRNewswire/ -- Dr. Mike Smith from Life Extension, a Fort Lauderdale, Fla-based organization dedicated to the extension of the healthy human lifespan, returns to The SUZANNE Show this week to discuss memory loss and aging. His appearance, which is one in a series devoted to nutrition and longevity, airs Wednesday, December 12, at 7 a.m. (ET/PT) on Lifetime Television. (Logo: http://photos.prnewswire.com/prnh/20121030/FL02749LOGO) Memory loss occurs...
HAYWARD, Calif., Dec. 3, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that it is again partnering with the Child Neurology Foundation (CNF) in support of the 4(th) annual Infantile Spasms Awareness Week, which will take place December 3 - 12, 2012. As part of this education effort, CNF has developed a website, www.infantilespasmsinfo.org, that provides information on infantile spasms from leading child neurologists and shares stories from...
HAYWARD, Calif., Dec. 3, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced that it is again partnering with the Child Neurology Foundation (CNF) to fund a $30,000 grant to support research into infantile spasms. Dr. Alex R. Paciorkowski of the University of Rochester Medical Center was selected by CNF as the recipient of its annual "Infantile Spasms Research Award." "Questcor has an ongoing commitment to CNF and the entire infantile spasms community,"...
LOS ANGELES, Nov. 29, 2012 /PRNewswire/ -- ArmaGen Technologies, Inc. today announced the closing of a $17 million Series A financing to support the development of brain-penetrating recombinant protein therapeutics. The lead investor is Boehringer Ingelheim Venture Fund, joined by Shire plc, Takeda Ventures, Inc., and Mitsui & Co. Global Investment, Inc. This funding will allow for expansion of existing operations, and the clinical development of potentially first-in-class...
MINNEAPOLIS – A new drug may bring help for people with insomnia, according to a study published in the November 28, 2012, online issue of Neurology®, the medical journal of the American Academy of Neurology. The drug, suvorexant, blocks the chemical messengers in the brain called orexins, which regulate wakefulness. Other drugs for insomnia affect different brain receptors. Taking the drug suvorexant increased the amount of time people spent asleep during the night, according...
SUNNYVALE, Calif., Nov. 29, 2012 /PRNewswire/ -- Amarantus Bioscience, Inc. (OTCQB: AMBS), a biotechnology company developing new treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centered on its proprietary anti-apoptosis therapeutic protein MANF, today announced that an independent peer-reviewed research paper entitled Upregulation of mesencephalic astrocyte-derived neurotrophic factor in glial cells is associated with ischemia-induced glial...
SAN DIEGO, Nov. 28, 2012 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today announced that the company will host an Analyst and Investor Day for financial analysts on Thursday, December 6, 2012, from 9:00 am to 12:00 pm EST in New York, NY. Members of the Cadence senior management team will provide an update...
SAN DIEGO, Nov. 28, 2012 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX) today announced that it has entered into settlement and license agreements with Perrigo Company (Nasdaq: PRGO; TASE), and its subsidiary, Paddock Laboratories, LLC, to resolve pending patent litigation involving OFIRMEV® (acetaminophen) injection. The settlement agreement includes a stipulation by the parties requesting dismissal with prejudice of the lawsuit filed by Cadence in the U.S. District...
Latest Neurology Reference Libraries
Stroke is a peer-reviewed medical journal published monthly by Lippincott Williams & Wilkins on behalf of the American Heart Association. As of May 2012, the current editor-in-chief is Marc Fisher (University of Massachusetts Medical School). Stroke covers research on cerebral circulation and related diseases, including clinical research on assessment of risk for stroke, diagnosis, prevention, and treatment, as well as rehabilitation. The audience base for Stroke includes neurologists,...
Herpes zoster (or zoster), is known as shingles or zona and is a viral disease characterized by painful skin rash with blisters in a limited area on one side of the body. Initial infection causes chickenpox. Once chickenpox is over the virus remains in the body and can cause shingles. It can become latent in the nerve cell bodies and sometimes in the dorsal root, cranial nerve, or autonomic ganglion. Years after initial infection, another breakout can cause a painful rash. The rash usually...
